Novo Nordisk discovers and develops innovative medicines and makes them accessible to patients throughout the world. Nearly a century of innovation and leadership has led to the development of a comprehensive portfolio of products and delivery systems for diabetes care, as well as in other therapeutic areas where the company can make a difference. Novo Nordisk, Inc., is the US affiliate of Novo Nordisk A/S. We are one of the world’s leading diabetes care company. The company’s US headquarters are located in Plainsboro, NJ, and the Novo Nordisk US business presence stretches from coast to coast -- from an insulin manufacturing plant in North Carolina to the Novo Nordisk Research Center in Seattle, WA.
We know there’s a lot of frustration and anger about the price of insulin. We also know there is much more to do to achieve real change. Novo Nordisk is committed to be an active part of the change that is needed and find real-world solutions for people living with diabetes.
We all sympathize with those who are suffering the devastation of natural disasters over the past weeks – Hurricanes Maria, Harvey and Irma, and the wildfires in California. Life may never be the same for many people.
As we continue to see more and more unimaginable images from the largest US natural disaster ever, our hearts ache for everyone affected by the recent hurricanes in Texas, Louisiana, Florida, and the Caribbean.